Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2008

01-03-2008 | Case Report

Coeliac disease in systemic lupus erythematosus: a case report

Authors: Antoni Hrycek, Urszula Siekiera

Published in: Rheumatology International | Issue 5/2008

Login to get access

Abstract

The case of a rare coexistence of systemic lupus erythematosus (SLE) with coeliac disease (CD) is described. Systemic lupus erythematosus was diagnosed prior to CD and initially SLE treatment was administered. After several years, when CD symptoms developed, the diagnosis was corrected and additional treatment with a gluten-free diet was applied with beneficial effects.
Literature
1.
Hrycek A, Siekiera U, Cieślik P, Szkróbka W (2005) HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol Int 26:1–6PubMedCrossRef
2.
Komatiereddy GR, Marshall JB, Aqel R, Spollen LE, Sharp GC (1995) Association of systemic lupus erythematosus and gluten enteropathy. South Med J 88:673–676CrossRef
3.
Hadjivassilious M, Sanders DS, Grünewald RA, Akil M (2004) Gluten sensitivity masquerading as systemic lupus erythematosus. Ann Rheum Dis 63:1501–1503CrossRef
4.
Varkel Y, Braester A, Suprun H, Nusem D, Horn Y (1989) Simultaneous occurrence of systemic lupus erythematosus and coeliac disease-like features. Postgrad Med J 65:600–602PubMedCrossRef
5.
Rensch MJ, Szyjkowski R, Shaffer RT, Fink S, Kopecky C, Grissmer L, Enzenhauer R, Kadakia S (2001) The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus. Am J Gatroenterol 96:1113–1115CrossRef
6.
Courtney PA, Patterson RN, Lee RJE, McMillan SA (2004) Systemic lupus erythematosus and coeliac disease. Lupus 13:214PubMedCrossRef
7.
Mirza N, Bonilla E, Phillips PE (2007) Celiac disease in patients with systemic lupus erythematosus: a case report and review of literature. Clin Rheumatol 26:827–828PubMedCrossRef
8.
Tan EM, Cohen AS, Fries J, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
9.
Collin P, Kaukinen K, Vogelsang M, Korponay-Szabo I, Sommer R, Schreler E, Volta U, Granito A, Veronesi L, Mascari F, Ocmant A, Ivarsson A, Legerqvist C, Burgin-Wolff A, Hadzisellmovic F, Furiano RI, Sidler MA, Mulder CJ, Goerres MS, Mearin ML, Ninaber MK, Gudmand-Hoyer E, Fabiani E, Catassi C, Tidlund H, Alainentalo L, Mak M (2005) Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17:85–91PubMedCrossRef
10.
Murdock AM, Johnston SD (2005) Diagnostic criteria for coeliac disease: time for change? Eur J Gastroenterol Hepatol 17:85–91CrossRef
11.
Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 102:330–354PubMed
12.
Mader R, Adawi M, Schonfeld S (1997) Malabsorption in systemic lupus erythematosus. Clin Exp Rheumatol 15:659–661PubMed
13.
Briani C, Zara G, Toffanin E, Ruggero S, Ferrarini A, De Lazzari F, Luca M, Faggian D, Grassivaro F, Ermani M, Pezzani R, Giometto B, D’odorico A (2005) Neurological complications of celiac disease and autoimmune mechanisms. Preliminary data of a prospective study in adult patients. Ann N Y Acad Sci 1051:148–155PubMedCrossRef
14.
Hrycek A, Pochopień-Kenig G, Ścieszka J (2007) Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity 40:217–222PubMedCrossRef
Metadata
Title
Coeliac disease in systemic lupus erythematosus: a case report
Authors
Antoni Hrycek
Urszula Siekiera
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0459-6

Other articles of this Issue 5/2008

Rheumatology International 5/2008 Go to the issue

Original Article

Effect of prayer on osteoarthritis and osteoporosis

Case Report

Successful treatment using tacrolimus plus corticosteroid in a patient with RA associated with MDS

Case Report

Pauci-immune glomerulonephritis associated with primary antiphospholipid syndrome

Original Article

The relation of hand functions with radiological damage and disease activity in rheumatoid arthritis

Original Article

Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet’s disease etiopathogenesis

Original Article

Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits